ES2132415T3 - Nuevos derivados de 5-pirrolil-2-piridilmetilsulfinilbencimidazol. - Google Patents

Nuevos derivados de 5-pirrolil-2-piridilmetilsulfinilbencimidazol.

Info

Publication number
ES2132415T3
ES2132415T3 ES94921865T ES94921865T ES2132415T3 ES 2132415 T3 ES2132415 T3 ES 2132415T3 ES 94921865 T ES94921865 T ES 94921865T ES 94921865 T ES94921865 T ES 94921865T ES 2132415 T3 ES2132415 T3 ES 2132415T3
Authority
ES
Spain
Prior art keywords
pct
pirrolil
piridilmetilsulfinilbencimidazol
new derivatives
sec
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES94921865T
Other languages
English (en)
Inventor
Su Ung Kim
Dong Yeon Kim
Gi Ju Sungwoo Chung
Sung Kol Chugong St Hong
Sung Jun Park
Sang Hoon Samchuli Nam
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Il Yang Pharmaceutical Co Ltd
Original Assignee
Il Yang Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Il Yang Pharmaceutical Co Ltd filed Critical Il Yang Pharmaceutical Co Ltd
Application granted granted Critical
Publication of ES2132415T3 publication Critical patent/ES2132415T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Abstract

LA PRESENTE INVENCION SE REFIERE A UN NUEVO COMPUESTO DERIVADO DE 5-PIRROLILO-2-PIRIDILMETILSULFINILOBENZIMIDAZOL QUE TIENE LA FORMULA GENERAL (I) Y SU SAL, EN LA QUE X REPRESENTA S, SO O SO{SUB, 2}, R{SUB, 1} Y R{SUB, 2} INDEPENDIENTEMENTE EL UNO DEL OTRO REPRESENTAN HIDROGENO O ALKILO, R{SUB, 3} REPRESENTA HIDROGENO, ALKILO C{SUB, 1}-C{SUB, 8}, -SR{SUB, 6}, -N(R{SUB, 7}){SUB, 2}, 1-PIPERIDINILO, 4-MORFOLINILO, 4-METILPIPERAZINA-1IL, 1-PIRROLIDINILO, -OR{SUB, 6}, O -O(CH{SUB, 2}){SUB, M}-Z, EN DONDE R{SUB, 6} REPRESENTA ALKILO C{SUB, 1}-C{SUB, 4}, ALQUENILO C{SUB, 2}-C{SUB, 4}, CICLOALKILO C{SUB, 3}-C{SUB, 10}, FLUORALKILO C{SUB, 2}-C{SUB, 5}, O FENILO O BENZILO, CADA UNO DE LOS CUALES SUSTITUIDO CON UNO O MAS HALOGENOS O ALKILO C{SUB, 1}C{SUB, 4} O ALKOXI OPCIONALMENTE SUSTITUIDO CON HALOGENO, R{SUB, 7} REPRESENTA HIDROGENO O ALKILO C{SUB, 1}-C{SUB, 5}, Z REPRESENTA UN GRUPO -O(CH{SUB, 2}){SUB, P}-OR{SUB, 8}, -O(CH{SUB, 2}){SUB, Q}-R{SUB, 9}, O -O(CH{SUB, 2}){SUB, R}-O(CH{SUB, 2}){SUB, S}-OR{SUB, 10}, EN DONDE P Y Q INDEPENDIENTEMENTE EL UNO DEL OTRO DENOTAN UN ENTERO DE 1 A 3, R Y S INDEPENDIENTEMENTE EL UNO DEL OTRO DENOTAN UN ENTERO DE 1 A 5, R{SUB, 8} REPRESENTA HIDROGENO, ALKILO BAJO, ARILO O ARALKILO, R{SUB, 9} REPRESENTA HIDROGENO, ALCOXICARBONILO, ARILO O HETEROARILO, Y R{SUB, 10} REPRESENTA HIDROGENO O ALKILO BAJO, M REPRESENTA UN ENTERO DE 2 A 10, Y R{SUB, 4} Y R{SUB, 5} INDEPENDIENTEMENTE EL UNO DEL OTRO REPRESENTAN HIDROGENO O ALKILO C{SUB, 1}-C{SUB, 5}, O CUANDO R{SUB, 4} Y R{SUB, 5} JUNTO CON LOS ATOMOS DE CARBONO ADYACENTES CON UN ANILLO DE PIRIDINA FORMAN UN ANILLO, R{SUB, 4} Y R{SUB, 3} O R{SU, 3} Y R{SUB, 5} REPRESENTAN -CH=CH-CH=CH-, -O(CH{SUB, 2}){SUB, N}-, -O(CH{SUB, 2}){SUB, N}O-, -CH{SUB, 2}(CH{SUB, 2}){SUB, N}- O -OCH=CH-, EN DONDE N DENOTA UN ENTERO DE 1 A 4. LA PRESENTE INVENCION TAMBIEN SE REFIERE A UN PROCESO PARA LA PREPARACION DEL COMPUESTO DE FORMULA (I), COMO SE DEFINE ANTERIORMENTE, Y SU USO COMO UN AGENTE ANTI-ULCERAS.
ES94921865T 1994-02-28 1994-07-22 Nuevos derivados de 5-pirrolil-2-piridilmetilsulfinilbencimidazol. Expired - Lifetime ES2132415T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
KR1019940003833A KR0179401B1 (ko) 1994-02-28 1994-02-28 신규한 5-피롤릴-2-피리딜메틸설피닐벤즈이미다졸 유도체

Publications (1)

Publication Number Publication Date
ES2132415T3 true ES2132415T3 (es) 1999-08-16

Family

ID=19378085

Family Applications (1)

Application Number Title Priority Date Filing Date
ES94921865T Expired - Lifetime ES2132415T3 (es) 1994-02-28 1994-07-22 Nuevos derivados de 5-pirrolil-2-piridilmetilsulfinilbencimidazol.

Country Status (17)

Country Link
US (1) US5703097A (es)
EP (1) EP0696281B1 (es)
JP (1) JP2690621B2 (es)
KR (1) KR0179401B1 (es)
CN (1) CN1048245C (es)
AT (1) ATE179976T1 (es)
AU (1) AU675564B2 (es)
BR (1) BR9406362A (es)
CA (1) CA2161542C (es)
DE (1) DE69418461T2 (es)
DK (1) DK0696281T3 (es)
ES (1) ES2132415T3 (es)
HU (1) HU220047B (es)
RU (1) RU2100358C1 (es)
TW (1) TW263499B (es)
WO (1) WO1995023140A1 (es)
ZA (1) ZA945621B (es)

Families Citing this family (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5840737A (en) 1996-01-04 1998-11-24 The Curators Of The University Of Missouri Omeprazole solution and method for using same
US6489346B1 (en) * 1996-01-04 2002-12-03 The Curators Of The University Of Missouri Substituted benzimidazole dosage forms and method of using same
AU6551198A (en) * 1997-05-30 1998-12-30 Dr. Reddy's Research Foundation Novel benzimidazole derivatives as antiulcer agents, process for their preparation and pharmaceutical compositions containing them
KR100299562B1 (ko) * 1998-12-29 2001-11-22 우재영 안정성을극대화시킨5-피롤릴-2-피리딜메틸설피닐벤즈이미다졸유도체함유미세과립
US6852739B1 (en) 1999-02-26 2005-02-08 Nitromed Inc. Methods using proton pump inhibitors and nitric oxide donors
KR100359256B1 (ko) * 1999-10-06 2002-11-04 한미약품공업 주식회사 란소프라졸의 개선된 제조방법
SG105539A1 (en) * 2002-03-01 2004-08-27 Il Yang Pharm Co Ltd Stabilized enteric-coated microgranules comprising 2-[(4-methoxy-3-methyl)-2-pyridinyl] methylsulfinyl-5-(1h-pyrrol-1-yl)-1h-benzimidazole and oral formulations comprising the microgranules
EP1534278A4 (en) * 2002-08-01 2006-09-06 Nitromed Inc NITROSED PROTONATE PUMP INHIBITORS, COMPOSITIONS AND USE METHOD
CN101098867B (zh) * 2005-03-25 2010-08-11 丽珠医药集团股份有限公司 取代的亚砜类化合物和其制备方法及用途
JP4837722B2 (ja) * 2005-03-25 2011-12-14 リブゾン ファーマシューティカル グループ インク． 置換スルホキシド化合物、その調製方法、およびその使用方法
KR101148399B1 (ko) * 2005-06-22 2012-05-23 일양약품주식회사 항궤양제 및 점막보호제를 함유하는 경구용 위장질환치료용 약제 조성물
WO2007075381A2 (en) * 2005-12-16 2007-07-05 Tap Pharmaceutical Products, Inc. Pharmaceutical compositions of ilaprazole
DK2046292T3 (da) * 2006-07-21 2010-06-07 Novartis Ag Formuleringer for benzimidazolylpyridylethere
US20100317689A1 (en) * 2006-09-19 2010-12-16 Garst Michael E Prodrugs of proton pump inhibitors including the 1h-imidazo[4,5-b] pyridine moiety
US20080103169A1 (en) 2006-10-27 2008-05-01 The Curators Of The University Of Missouri Compositions comprising acid labile proton pump inhibiting agents, at least one other pharmaceutically active agent and methods of using same
DK2102192T3 (da) * 2006-12-29 2013-03-04 Il Yang Pharmaceutical Company Ltd Racemisk ilaprazol i fast form
US20080200515A1 (en) * 2006-12-29 2008-08-21 Tap Pharmaceutical Products Inc. Solid state forms of enantiopure ilaprazole
WO2008130863A2 (en) * 2007-04-11 2008-10-30 Auspex Pharmaceuticals, Inc. Substituted benzimidazoles
KR101044880B1 (ko) 2008-06-12 2011-06-28 일양약품주식회사 항궤양제 화합물의 합성에 유용한 중간체의 제조방법
CZ302548B6 (cs) * 2008-10-22 2011-07-07 Zentiva, A.S. Zpusob výroby 5-amino-2-[(4-methoxy-3-methyl-2-pyridyl)methylthio]-1H-benzimidazolu a 5-(1H-pyrrol-1-yl)-2-[(4-methoxy-3-methyl-2-pyridyl)methylthio]-1H-benzimidazolu
CN102140092B (zh) * 2010-02-03 2013-05-29 丽珠医药集团股份有限公司 艾普拉唑盐的水合物及其制备方法和用途
WO2013108068A1 (en) 2012-01-21 2013-07-25 Jubilant Life Sciences Limited Process for the preparation of 2-pyridinylmethylsulfinyl benzimidazoles, their analogs and optically active enantiomers
CN103073536B (zh) * 2013-01-17 2015-06-24 丽珠医药集团股份有限公司 一种艾普拉唑的制备方法
CN105218522B (zh) * 2014-06-25 2019-04-02 江苏奥赛康药业股份有限公司 一种右旋艾普拉唑化合物及其药物组合物
CN105461692A (zh) * 2014-09-04 2016-04-06 江苏奥赛康药业股份有限公司 艾普拉唑钠化合物及其药物组合物
CA3049728A1 (en) * 2017-01-10 2018-07-19 Eth Zurich Inhibitors of g-protein-coupled receptor kinase 2 and their use
KR102027388B1 (ko) 2017-11-15 2019-10-01 주식회사 다산제약 고순도 일라프라졸 결정형 b의 제조방법
CN109053685B (zh) * 2018-06-22 2020-09-22 丽珠医药集团股份有限公司 一种含艾普拉唑钠的药物组合物及其制备方法
CN108685918B (zh) * 2018-06-22 2021-02-09 丽珠医药集团股份有限公司 一种含艾普拉唑或其盐的药物组合物及其制备方法
KR102250509B1 (ko) 2020-12-09 2021-05-11 유니셀랩 주식회사 새로운 일라프라졸/자일리톨 공결정
CN114163419A (zh) * 2021-12-24 2022-03-11 辰欣药业股份有限公司 一种兰索拉唑的制备方法

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1234058A (es) * 1968-10-21 1971-06-03
SE7804231L (sv) * 1978-04-14 1979-10-15 Haessle Ab Magsyrasekretionsmedel
US4225431A (en) * 1978-12-28 1980-09-30 Pepsico, Inc. Process and apparatus for the treatment of aqueous waste materials
SE8300736D0 (sv) * 1983-02-11 1983-02-11 Haessle Ab Novel pharmacologically active compounds
IL75400A (en) * 1984-06-16 1988-10-31 Byk Gulden Lomberg Chem Fab Dialkoxypyridine methyl(sulfinyl or sulfonyl)benzimidazoles,processes for the preparation thereof and pharmaceutical compositions containing the same
JPS6185383A (ja) * 1984-10-02 1986-04-30 Banyu Pharmaceut Co Ltd ベンズイミダゾ−ル誘導体，その製造法およびそれを含有する医薬
JPS62108879A (ja) * 1985-11-05 1987-05-20 Grelan Pharmaceut Co Ltd 置換ベンズイミダゾ−ル類
FI90544C (fi) * 1986-11-13 1994-02-25 Eisai Co Ltd Menetelmä lääkeaineina käyttökelpoisten 2-pyridin-2-yyli-metyylitio- ja sulfinyyli-1H-bensimidatsolijohdannaisten valmistamiseksi
KR0142815B1 (ko) * 1994-12-02 1998-07-15 정도언 신규한 5-피롤릴-6-할로게노-2피리딜메틸설피닐벤즈이미다졸 유도체

Also Published As

Publication number Publication date
WO1995023140A1 (en) 1995-08-31
DE69418461T2 (de) 1999-09-09
KR0179401B1 (ko) 1999-03-20
AU7239994A (en) 1995-09-11
DE69418461D1 (de) 1999-06-17
KR950025038A (ko) 1995-09-15
RU2100358C1 (ru) 1997-12-27
DK0696281T3 (da) 1999-11-01
CA2161542C (en) 1999-11-02
TW263499B (es) 1995-11-21
HU9503401D0 (en) 1996-01-29
JPH09503000A (ja) 1997-03-25
HU220047B (hu) 2001-10-28
BR9406362A (pt) 1996-02-13
EP0696281B1 (en) 1999-05-12
ZA945621B (en) 1995-03-07
ATE179976T1 (de) 1999-05-15
CA2161542A1 (en) 1995-08-31
JP2690621B2 (ja) 1997-12-10
US5703097A (en) 1997-12-30
HUT75123A (en) 1997-04-28
AU675564B2 (en) 1997-02-06
CN1121714A (zh) 1996-05-01
CN1048245C (zh) 2000-01-12
EP0696281A1 (en) 1996-02-14

Similar Documents

Publication Publication Date Title
ES2132415T3 (es) Nuevos derivados de 5-pirrolil-2-piridilmetilsulfinilbencimidazol.
DE69413542T2 (de) Perhydroisoindolderivate als substanz p antagonisten
BR9407239A (pt) Azadioxacicloalquenos substituídos
HK1023987A1 (en) Sulphinic acid derivatives, method for producing, and their use
PL314188A1 (en) Novel derivatives of benzoguanidine, method of obtaining them and their application in pharmaceutical compositions
ZA959451B (en) 2,2-Dichloroalkanecarboxylic acids process of their production and pharmaceutical agents containing these
FI970147A (fi) Triatsoliyhdisteitä ja niiden käyttö dopamiini-D3-ligandeina
BR9408244A (pt) Derivados de azabiciclo[3.2.0]heptano N-substituídos
GR3021736T3 (en) N-substitued 3-azabicyclo 3.2.0]heptane derivatives useful as neuroleptic agents etc.
BR9610175A (pt) Composto processo de preparação do composto composição farmacêutica e utilização do composto
ES2102295B1 (es) Nuevos compuestos derivados de la n-benzoilmetil-piperidina.
HRP950437A2 (en) N-substituted azabicycloheptane derivatives, their production and use
ZA9480B (en) Pyrrolidine derivatives their preparation and medicaments containing them
ES2140683T3 (es) Procedimiento para preparar compuestos de benzopirano.
PT99280A (pt) Processo de preparacao de derivados do indolo e de composicoes farmaceuticas
ATE173259T1 (de) Verfahren zur herstellung von indolizinderivaten
HU9600300D0 (en) Thiocarbamoyl derivatives using as antimicrobial agents and process for producing of these
SE9401596D0 (sv) New compounds

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 696281

Country of ref document: ES